About Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
During the past decade, Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
857
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology" are
"Hepatitis B, Chronic" (2 trials). Many other conditions were trialed in "Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology" in a lesser frequency.
Clinical Trials Intervention Types at Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
Most popular intervention types in "Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Adefovir" (1 trials), "Entecavir" (1 trials), "Peg-IFN alfa-2a" (1 trials), "Placebo" (1 trials) and "peginterferon alfa-2a [Pegasys]" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
The vast majority of trials in "Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology" are
2 trials for "All" genders.
Clinical Trials Status at Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology
Currently, there are NaN active trials in "Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chang Gung Medical Foundation - Keelung; Dept. of Hepato-Gastroenterology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".